FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lasilactone capsules (Mawdsley-Brooks & Company Ltd) 30 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorhexidine gluconate 0.02% solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Stannous fluoride 0.4% dental gel sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 1 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Indapamide 1.25mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Indapamide 1.25mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Compound Syrup of Glycerin, Lemon & Honey (Bell,Sons & Co (Druggists) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amiloride 5mg / Bumetanide 1mg tablets (Chemidex Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Compound Syrup of Glycerin, Lemon & Honey (Bell,Sons & Co (Druggists) Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amiloride 5mg / Bumetanide 1mg tablets (Chemidex Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5mL syrup VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Bell's Glycerin and Blackcurrant Cough syrup (Bell,Sons & Co (Druggists) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Actavis UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 1g oral powder sachets 8 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Bell's Glycerin and Blackcurrant Cough syrup (Bell,Sons & Co (Druggists) Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) 8 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) 10 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Zentiva Pharma UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone acetonide 40mg/mL injection suspension 1mL prefilled syringe VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Macrogol 4000 10g oral powder sachets sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 2.7% solution for injection 500ml polyethylene bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Dexcel-Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Viatris UK Healthcare Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Dexcel-Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Eno effervescent powder sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely lornoxicam 8 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phytomenadione 1mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx lancets 0.31mm/30gauge (Disposable Medical Equipment Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx lancets 0.31mm/30gauge (Disposable Medical Equipment Ltd) 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely ifosfamide 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Naloxone hydrochloride 20mcg/mL injection solution 2mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Squill liquid extract VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5ml oral solution (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5ml oral solution (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Somatropin (rbe) 4.95mg/1.5ml solution for injection cartridges VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gentamicin 10mg/mL injection solution 2mL vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tilade 2mg/dose inhaler CFC free (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tilade 2mg/dose inhaler CFC free (Mawdsley-Brooks & Company Ltd) 112 dose VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Burns cream VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme cafe (Vichy) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme chocolate (Vichy) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme olive (Vichy) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme cafe (Vichy) 6 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme chocolate (Vichy) 6 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dermablend cover creme olive (Vichy) 6 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cephradine 250mg/5mL syrup VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely phenylbutazone 200 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Dermablend setting powder VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Feminax Express 342mg tablets (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neokay 1mg capsules (Neoceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phytomenadione 1mg capsules 12 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ibuprofen lysine 200mg tablets 8 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Sigma Pharmaceuticals Plc) 21 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Feminax Express 342mg tablets (Bayer Plc) 8 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Feminax Express 342mg tablets (Bayer Plc) 16 tablet 2 x 8 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neokay 1mg capsules (Neoceuticals Ltd) 12 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neokay 1mg capsules (Neoceuticals Ltd) 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorhexidine gluconate 5% concentrated solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chamomile extracts 10.5% ointment VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sunsense lip balm SPF 50 (Ego Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sunscreen lip balm 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sunsense lip balm SPF 50 (Ego Pharmaceuticals) 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Arrow Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Arrow Generics Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapor-permeable adhesive film dressing with absorbent pad 6cm x 7cm VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nabilone 1mg capsules (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nabilone 1mg capsules (A A H Pharmaceuticals Ltd) 20 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 33 of 86 Next End


This concept is not in any reference sets

Back to Start